These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 23985380

  • 1. Complex atrial arrhythmias as first manifestation of catecholaminergic polymorphic ventricular tachycardia: an unusual course in a patient with a new mutation in ryanodine receptor type 2 gene.
    Lawrenz W, Krogmann ON, Wieczorek M.
    Cardiol Young; 2014 Aug; 24(4):741-4. PubMed ID: 23985380
    [Abstract] [Full Text] [Related]

  • 2. S4153R is a gain-of-function mutation in the cardiac Ca(2+) release channel ryanodine receptor associated with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation.
    Zhabyeyev P, Hiess F, Wang R, Liu Y, Wayne Chen SR, Oudit GY.
    Can J Cardiol; 2013 Aug; 29(8):993-6. PubMed ID: 23498838
    [Abstract] [Full Text] [Related]

  • 3. A novel mutation in the RYR2 gene leading to catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation: dose-dependent arrhythmia-event suppression by β-blocker therapy.
    Kazemian P, Gollob MH, Pantano A, Oudit GY.
    Can J Cardiol; 2011 Aug; 27(6):870.e7-10. PubMed ID: 21652165
    [Abstract] [Full Text] [Related]

  • 4. A novel RyR2 mutation in a 2-year-old baby presenting with atrial fibrillation, atrial flutter, and atrial ectopic tachycardia.
    Di Pino A, Caruso E, Costanzo L, Guccione P.
    Heart Rhythm; 2014 Aug; 11(8):1480-3. PubMed ID: 24793461
    [No Abstract] [Full Text] [Related]

  • 5. Catecholaminergic polymorphic ventricular tachycardia.
    Liu N, Ruan Y, Priori SG.
    Prog Cardiovasc Dis; 2008 Aug; 51(1):23-30. PubMed ID: 18634915
    [Abstract] [Full Text] [Related]

  • 6. Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features.
    Bhuiyan ZA, van den Berg MP, van Tintelen JP, Bink-Boelkens MT, Wiesfeld AC, Alders M, Postma AV, van Langen I, Mannens MM, Wilde AA.
    Circulation; 2007 Oct 02; 116(14):1569-76. PubMed ID: 17875969
    [Abstract] [Full Text] [Related]

  • 7. Unusual clinical presentation in a family with catecholaminergic polymorphic ventricular tachycardia due to a G14876A ryanodine receptor gene mutation.
    Allouis M, Probst V, Jaafar P, Schott JJ, Le Marec H.
    Am J Cardiol; 2005 Mar 01; 95(5):700-2. PubMed ID: 15721128
    [Abstract] [Full Text] [Related]

  • 8. Catecholaminergic polymorphic ventricular tachycardia found in an adolescent after a methylenedioxymethamphetamine and marijuana-induced cardiac arrest.
    Diffley M, Armenian P, Gerona R, Reinhartz O, Avasarala K.
    Crit Care Med; 2012 Jul 01; 40(7):2223-6. PubMed ID: 22584762
    [Abstract] [Full Text] [Related]

  • 9. [Catecholaminergic polymorphic ventricular tachycardia is a rare inherited heart disease].
    Holst AG, Tfelt-Hansen J, Olesen MS, Theilade J, Winkel BG, Christensen AH, Bundgaard H, Haunsø S, Svendsen JH.
    Ugeskr Laeger; 2010 Aug 02; 172(31):2140-4. PubMed ID: 20670590
    [Abstract] [Full Text] [Related]

  • 10. A novel variant in RyR2 causes familiar catecholaminergic polymorphic ventricular tachycardia.
    Bosch C, Campuzano O, Sarquella-Brugada G, Cesar S, Perez-Serra A, Coll M, Mademont I, Mates J, Del Olmo B, Iglesias A, Brugada J, Petersen V, Brugada R.
    Forensic Sci Int; 2017 Jan 02; 270():173-177. PubMed ID: 27988446
    [Abstract] [Full Text] [Related]

  • 11. Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives.
    van der Werf C, Nederend I, Hofman N, van Geloven N, Ebink C, Frohn-Mulder IM, Alings AM, Bosker HA, Bracke FA, van den Heuvel F, Waalewijn RA, Bikker H, van Tintelen JP, Bhuiyan ZA, van den Berg MP, Wilde AA.
    Circ Arrhythm Electrophysiol; 2012 Aug 01; 5(4):748-56. PubMed ID: 22787013
    [Abstract] [Full Text] [Related]

  • 12. Catecholaminergic polymorphic ventricular tachycardia in a child: a case report.
    Garabedian L, Verryckt A, Panzer J, De Wolf D.
    Acta Paediatr; 2008 Jan 01; 97(1):127-9. PubMed ID: 18052993
    [Abstract] [Full Text] [Related]

  • 13. Novel ryanodine receptor 2 mutation associated with a severe phenotype of catecholaminergic polymorphic ventricular tachycardia.
    LaPage MJ, Russell MW, Bradley DJ, Dick M.
    J Pediatr; 2012 Aug 01; 161(2):362-4. PubMed ID: 22608700
    [Abstract] [Full Text] [Related]

  • 14. Deadly proposal: a case of catecholaminergic polymorphic ventricular tachycardia.
    Heiner JD, Bullard-Berent JH, Inbar S.
    Pediatr Emerg Care; 2011 Nov 01; 27(11):1065-8. PubMed ID: 22068070
    [Abstract] [Full Text] [Related]

  • 15. Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations.
    Swan H, Laitinen P, Kontula K, Toivonen L.
    J Cardiovasc Electrophysiol; 2005 Feb 01; 16(2):162-6. PubMed ID: 15720454
    [Abstract] [Full Text] [Related]

  • 16. A classic electrocardiographic manifestation of catecholaminergic polymorphic ventricular tachycardia.
    Richter S, Gebauer R, Hindricks G, Brugada P.
    J Cardiovasc Electrophysiol; 2012 May 01; 23(5):560. PubMed ID: 21806698
    [No Abstract] [Full Text] [Related]

  • 17. Sudden death in a young man with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation.
    Pizzale S, Gollob MH, Gow R, Birnie DH.
    J Cardiovasc Electrophysiol; 2008 Dec 01; 19(12):1319-21. PubMed ID: 18554199
    [Abstract] [Full Text] [Related]

  • 18. A Clinical Case of Catecholaminergic Polymorphic Ventricular Tachycardia: The Clinical Suspicious and the Need of Genetics.
    Del Franco A, Gualandi F, Malagù M, Ferlini A, Xiao D, Ferrari R, Bertini M.
    Cardiology; 2017 Dec 01; 138(2):69-72. PubMed ID: 28605744
    [Abstract] [Full Text] [Related]

  • 19. High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening.
    Haugaa KH, Leren IS, Berge KE, Bathen J, Loennechen JP, Anfinsen OG, Früh A, Edvardsen T, Kongsgård E, Leren TP, Amlie JP.
    Europace; 2010 Mar 01; 12(3):417-23. PubMed ID: 20106799
    [Abstract] [Full Text] [Related]

  • 20. Long-Term Prognosis of Catecholaminergic Polymorphic Ventricular Tachycardia Patients With Ryanodine Receptor (RYR2) Mutations.
    Yamazoe M, Furukawa T.
    Circ J; 2016 Aug 25; 80(9):1892-4. PubMed ID: 27523319
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.